ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Changes Center Core Grants Guidelines To Permit Payment for Control Program Directors

October 29, 1982

Varmus: NCI Needs To Rethink, Review; Programs Must Be “At A High Level”

November 12, 2010

Breslow Reported Choice As HEW Asst. secretary

January 28, 1977

Van Potter Wins Bristol-Myers Award

April 24, 1981

Guest Editorial: Don Berry On Cancer Centers Publishing Comparative Survival Data

March 18, 2011

Funding Opportunities listed.

May 21, 2004